Introduction to Psychoneuroimmunology

Introduction to Psychoneuroimmunology

Volumn , Issue , 2012, Pages

  Daruna, Jorge H ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85013844670     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/C2009-0-01965-5     Document Type: Book

References (511)

1. Ader R. Psychosomatic and psychoimmunologic research. Psychosomatic Medicine 1980, 42:307-321.
2. Psychoneuroimmunology 1981, Academic Press, New York. R. Ader (Ed.).
3. Ader R. Historical perspective on psychoneuroimmunology. Psychoneuroimmunology, Stress, and Infection 1995, CRC Press, Orlando. H. Friedman (Ed.).
4. Besedovsky H.O., del Rey A. Physiology of psychoneuroimmunology: a personal view. Brain, Behavior, and Immunity 2007, 21:33-44.
5. Blalock J.E., Smith E.M. Conceptual development of the immune system as a sixth sense. Brain, Behavior, and Immunity 2007, 21:23-33.
6. Cohen M.N. Health and the Rise of Civilization 1989, Yale University Press, New Haven.
7. Dantzer R., Kelley K.W. Twenty years of research on cytokine induced sickness behavior. Brain, Behavior, and Immunity 2007, 21:153-160.
8. Engel G.F. The need for a new medical model: a challenge for biomedicine. Science 1977, 196:129-136.
9. Fábrega H. Evolution of Sickness and Healing 1997, University of California Press, Berkley.
10. Finger S. Origins of Neuroscience: a History of Explorations into Brain Function 1994, Oxford University Press, New York.
11. Glaser R. Stress-induced immune dysregulation and its importance for human health: a personal history of psychoneuroimmunology. Brain, Behavior, and Immunity 2005, 19:3-11.
12. Golub E.S. The Limits of Medicine: How Science Shapes Our Hope for the Cure 1994, University of Chicago Press, Chicago.
13. Goodall J. The Chimpanzees of Gombe: Patterns of Behavior 1986, Harvard University Press, Cambridge.
14. Hughes C.H. The nervous system in disease and the practice of medicine from a neurologic standpoint. Journal of the American Medical Association 1894, 22:897-908.
15. Theories and Philosophies of Medicine with Particular Reference to Greco-Arab Medicine, Ayurveda and Traditional Chinese Medicine 1973, Institute of History of Medicine and Medical Research, Tughlaqabad, New Delhi, no. 62. 2nd ed.
16. Irwin M.R. Human psychoneuroimmunology: 20 years of discovery. Brain, Behavior, and Immunity 2008, 22:129-139.
17. Kaptchuk T.J. The Web that has No Weaver: Understanding Chinese Medicine 1983, Congdon R. Weed, New York.
18. Immunology of the Nervous System 1997, Oxford University Press, New York. R.W. Keane, W.F. Hickey (Eds.).
19. Metal'nikov S., Chorine V. Role de reflexes conditionnels dans l'immunite. Annales de l'Institut Pasteur 1926, 40:900.
20. Porter R. The Greatest Benefit to Mankind: a Medical History of Humanity 1997, W.W. Norton & Company, New York.
21. Sigerist H.E. A History of Medicine (Vol. 1). Primitive and Archaic Medicine 1951, Oxford University Press, New York.
22. Sigerist H.E. A History of Medicine (Vol. 2). Early Greek, Hindu, and Persian Medicine 1961, Oxford University Press, New York.
23. Silverstein A.M. A History of Immunology 2009, Elsevier, New York. 2nd ed.
24. Solomon G.F. From Psyche to Soma and Back: Tales of Psychosocial Medicine 2000, Xlibris Corporation, Philadelphia.
25. Sternberg E.M. The Balance Within: the Science Connecting Health and Emotions 2000, Freeman, New York.
26. Val Alphen J., Aris A. Oriental Medicine: an Illustrated Guide to the Asian Arts of Healing 1996, Shambhala, Boston.
27. Whorton J.C. Nature Cures: the History of Alternative Medicine in America 2002, Oxford University Press, New York.
28. Bonasio R., Tu S., Reinberg D. Molecular signals of epigenetic states. Science 2010, 330:612-616.
29. Clark W.R. In Defense of Self: How the Immune System Really Works 2008, Oxford University Press, New York.
30. Cohen I.R. Tending Adam's Garden: Evolving the Cognitive Immune Self 2000, Academic Press, San Diego.
31. Cruse J.M., Lewis R.E. Atlas of Immunology 1999, CRC Press, Boca Raton.
32. English B.K., Schroeder H.W., Wilson C.B. Immaturity of the fetal and neonatal immune system,. Clinical Immunology: Principles and Practice Vol 1 2001, Mosby, London. 2nd ed. R.R. Rich, T.A. Fleisher, W.T. Shearer (Eds.).
33. Fagarasan S., Honjo T. T-independent immune response: new aspects of B cell biology. Science 2000, 290:89-92.
34. Hayday A., Viney J.L. The ins and outs of body surface immunology. Science 2000, 290:97-100.
35. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000, 290:92-97.
36. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system. Science 2010, 330:1768-1773.
37. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
38. Medzhitov R., Janeway C.A. Decoding the patterns of self and nonself by the innate immune system. Science 2002, 296:298-300.
39. Pabst H.F., Kreth H.W. Ontogeny of the immune response as a basis of childhood disease. Journal of Pediatrics 1980, 97:519-534.
40. Fundamental Immunology 1999, Lippincott-Raven Press, Philadelphia. 4th ed. W.E. Paul (Ed.).
41. Rabin B.S. Stress, Immune Function, and Health: the Connection 1999, Wiley-Liss, New York.
42. Ravetch J.V., Lanier L.L. Immune inhibitory receptors. Science 2000, 290:84-89.
43. Clinical Immunology Principles and Practice 2008, Elsevier/Mosby, Philadelphia. 3rd ed. R.R. Rich, T.A. Flisher, W.T. Shearer, H.W. Schroeder, A.J. Frew, C.M. Weyand (Eds.).
44. Roitt I.M., Delves P.J. Roitt's Essential Immunology 2001, Blackwell Science, Oxford. 10th ed.
45. Vivier E., Raulet D.H., Moretta A., et al. Innate or adaptive immunity The example of natural killer cells. Science 2011, 331:44-49.
46. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D. Felter, N. Cohen (Eds.).
47. Clark R. Somatogenic hormone and insulin like growth factor-1: stimulation of lymphopoiesis and immune function. Endocrine Reviews 1997, 18:157-179.
48. Neuroendocrinology in Physiology and Medicine 2000, Humana Press, Totowa. P.M. Conn, M.E. Freeman (Eds.).
49. Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Anti-inflammatory effects of insulin and the pro-inflammatory effects of glucose. Seminars in Thoracic and Cardiovascular Surgery 2006, 18:293-301.
50. Davis S.L. Environmental modulation of the immune system via the endocrine system. Domestic Animal Endocrinology 1998, 15:283-289.
51. Geara A.S., Castellanos M.R., Bassil C., et al. Effects of parathyroid hormone on immune function. Clinical and Developmental Immunology 2010, 2010:1-10.
52. Genaro A.M., Klecha A.J., Frick L.R., Barrairo Arcos M.L., Cremaschi G.A. Thyroid hormone modulation of immunity: its participation in chronic stress-induced immune alterations. Current Immunology Reviews 2010, 6:339-347.
53. Gouin J.-P., Carter C.S., Pournajafi-Nazarloo H., et al. Marital behavior, oxytocin, vasopressin and wound healing. Psychoneuroendocrinology 2010, 35:1082-1090.
54. Endocrinology: Adult and Pediatric 2010, Vols. 1-2. Saunders/Elsevier, Philadelphia. 6th ed. J.L. Jameson, L.J. De Groot (Eds.).
55. Jiang Y., Yoshida A., Ishioka C., et al. Parathyroid hormone inhibits immunoglobulin production without affecting cell growth in human B-cells. Clinical Immunology and Immunopathology 1992, 65:286-293.
56. Juge-Aubrey C.E., Henrichot E., Meier C.A. Adipose tissue: a regulator of inflammation. Best Practice & Research Clinical Endocrinology & Metabolism 2005, 19:547-566.
57. Khan W.I., Ghia J.I. Gut hormones: emerging role in immune activation and inflammation. Clinical & Experimental Immunology 2010, 161:19-27.
58. Klecha A.J., Genaro A.M., Lysionek A.E., et al. Experimental evidence pointing to the bidirectional interaction between the immune system and the thyroid axis. International Journal of Immunopharmacology 2000, 22:491-500.
59. Lopez-Meza J.E., Lara-Zarate L., Ochoa-Zarzosa A. Effects of prolactin on innate immunity of infectious diseases. The Open Neuroendocrinology Journal 2010, 3:175-179.
60. Malarkey W.B., Mills P.J. Endocrinology: the active partner in PNI research. Brain, Behavior, and Immunity 2007, 21:161-168.
61. Neuroimmunomodulation: molecular aspects, integrated systems, and clinical advances. Annals of the New York Academy of Sciences 1998, 840:1-856. S.M. McCann, E.M. Sternberg, J.M. Lipton (Eds.).
62. McCusker R.H, Strle K., Broussard S.R., et al. Psychoneuroimmunology 2010, Vol. 1:171-191. Elsevier, San Diego. 4th ed. R. Ader (Ed.).
63. Nass R.M., Gaylinn B.D., Rogol A.D., Thorner M.O. Ghrelin and growth hormone: story in reverse. Proceedings of the National Academy of Sciences of the USA 2010, 107:8501-8502.
64. Nillni E.A. Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Frontiers in Neuroendocrinology 2010, 31:134-156.
65. Pace T.W.W., Raison C.L., Miller A.H. Neuroendocrine-immune interactions: implications for health and behavior. Hormone/Behavior Relations of Clinical Importance: Endocrine Systems Interacting with Brain and Behavior 2009, 487-567. Academic Press/Elsevier, San Diego. R.T. Rubin, D.W. Pfaff (Eds.).
66. Reggiani P.C., Morel G.I., Console G.M., et al. The thymus-neuroendocrine axis: physiology, molecular biology, and theraputic potential of the thymic peptide thymulin. Annals of the New York Academy of Sciences 2009, 1153:98-106.
67. Schoneveld O.J.L.M., Cidlowski J.A. Psychoneuroimmunology 2010, Vol. 1:45-61. Elsevier, San Diego. 4th ed. R. Ader (Ed.).
68. Smith T.J. Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases. Pharmacological Reviews 2010, 62:199-236.
69. Fundamental Neuroscience 2008, Academic Press/Elsevier, San Diego. 3rd ed. L. Squire, D. Berg, F.E. Bloom, S. DuLac, A. Ghosh, N. Spitzer (Eds.).
70. Straub R.H., Cutolo M., Buttgereitt F., Pongratz G. Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases. Journal of Internal Medicine 2010, 267:543-560.
71. Tzanno-Martins C., Futata E., Jorgetti V., Duarte A.J.S. Restoration of impaired T-cell proliferation after parathyroidectomy in hemodialysis patients. Nephron 2000, 84:224-227.
72. Vollmar A.M. The role of atrial natriuretic peptide in the immune system. Peptides 2005, 26:1086-1094.
73. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
74. Berthoud H.-R., Neuhuber W.L. Functional and chemical anatomy of the afferent vagal system. Autonomic Neuroscience: Basic & Clinical 2000, 85:1-17.
75. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain, Behavior, and Immunity 2000, 16:622-653.
76. Burnstock G. Autonomic neurotransmission: 60 years since Sir Henry Dale. Annual Review of Pharmacology and Toxicology 2009, 49:1-30.
77. Cerqueira J.J., Almeida O.F.X., Sousa N. The stressed prefrontal cortex: left right!. Brain, Behavior, and Immunity 2008, 22:630-638.
78. Cohen F., Kearney K.A., Zegans L.S., et al. Differential immune system changes with acute and persistent stress for optimists vs. pessimists. Brain, Behavior, and Immunity 1999, 13:155-174.
79. Cohen J.J. Individual variability and immunity. Brain, Behavior, and Immunity 1999, 13:76-79.
80. Craig A.D. How do you feel now The anterior insula and human awareness. Nature Reviews Neuroscience 2009, 10:59-70.
81. Davidson R.J., Coe C.C., Dolski I., Donzella B. Individual differences in prefrontal activation asymmetry predict natural killer cell activity at rest and in response to challenge. Brain, Behavior, and Immunity 1999, 13:93-108.
82. Delgado M., Ganea D. Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain, Behavior, and Immunity 2008, 22:1146-1151.
83. Felten D.L., Cohen N., Ader R., et al. Central neural circuits involved in neural-immune interactions. Psychoneuroimmunology 1991, 3-25. Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
84. The New Cognitive Neurosciences 2000, MIT Press, Cambridge. 2nd ed. M.S. Gazzaniga (Ed.).
85. Gershon M.D. The Second Brain 1998, Harper Collins, New York.
86. Geschwind N., Behan P.O. Laterality, hormones and immunity. Cerebral Dominance: The Biological Foundation 1984, Harvard Press, Cambridge. N. Geschwind, A.M. Galaburda (Eds.).
87. Geschwind N., Galaburda A.M. Cerebral lateralization: biological mechanisms, associations, and pathology: III. a hypothesis and a program for research. Archives of Neurology 1985, 43:634-654.
88. Fundamental Neuroscience for Basic and Clinical Applications 2006, Churchill Livingston/Elsevier, Philadelphia. 3rd ed. D.E. Haines (Ed.).
89. Handbook of Personality Psychology 1997, Academic Press, San Diego. R. Hogan, J. Johnson, S. Briggs (Eds.).
90. Jänig W. Neurobiology of visceral afferent neurons: neuroanatomy, functions, organ regulations and sensations. Biological Psychology 1996, 42:29-51.
91. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. Journal of Neuroscience 2007, 27:8877-8884.
92. Jurkowski M., Trojniar W., Barsman A., et al. Peripheral blood natural killer cell cytotoxicity after damage to the limbic system in the rat. Brain, Behavior, and Immunity 2001, 15:93-113.
93. Kemeny M.E., Lauderslager M.L. Beyond stress: the role of individual difference factors in psychoneuroimmunology. Brain, Behavior, and Immunity 1999, 13:73-75.
94. Kern M.L., Friedman H.S. Personality and pathways of influence on physical health. Social and Personality Psychology Compass 2011, 5:76-87.
95. Koch H.J., Uyanic G., Bogdahn U., Ickenstein G.W. Relationship between laterality and immune response after acute cerebral ischemia. Neuroimmunomodulation 2006, 13:8-12.
96. Maier S.F. Bi-directional immune-brain communication: implications for understanding stress, pain, and cognition. Brain, Behavior, and Immunity 2003, 17:69-85.
97. Meador K.J., Loring D.W., Ray P.G., Helman S.W., Vazquez B.R., Neveu P.J. Role of cerebral lateralization in the control of immune processes in humans. Annals of Neurology 2004, 55:840-844.
98. Miller G.E., Cohen S., Rabin B.S., et al. Personality and tonic cardiovascular, neuroendocrine, and immune parameters. Brain, Behavior, and Immunity 1999, 13:109-123.
99. Quan N., Banks W.A. Brain-immune communication pathways. Brain, Behavior, and Immunity 2007, 21:727-735.
100. Sanders V.M., Straub R.H. Norepinephrine, the β-adrenergic receptor, and immunity. Brain, Behavior, and Immunity 2002, 16:290-332.
101. Schedlowski M., Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain, Behavior, and Immunity 2010, 24:176-185.
102. Fundamental Neuroscience 2008, Academic Press/Elsevier, San Diego. L. Squire, D. Berg, F.E. Bloom, S. duLac, A. Ghosh, N. Spitzer (Eds.).
103. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Reviews Immunology 2006, 6:318-328.
104. Thayer J.F., Sternberg E.M. Neural aspects of immunomodulation: focus on the vagus nerve. Brain, Behavior, and Immunity 2010, 24:1223-1228.
105. Tracey K.J. Understanding immunity requires more than immunology. Nature Immunology 2010, 11:561-564.
106. Van Der Kleij H.P.M., Bienenstock J. Significance of sensory neuropeptides and the immune response. Psychoneuroimmunology 2007, Vol. 1:97-129. Academic Press, San Diego. 4th ed. R. Ader (Ed.).
107. Vinken P.J., Bruyn G.W. The autonomic nervous system (part 1): normal functions. Handbook of Clinical Neurology 1999, Vol. 74. Elsevier, Amsterdam. O. Apperzeller (Ed.).
108. Textbook of Gastroenterology 1999, Vol. 1. Lippincott Williams & Wilkins, Philadelphia. T. Yamada (Ed.).
109. Berczi I. The stress concept: an historical perspective of Hans Selye's contributions. Stress, Stress Hormones, and the Immune System 1997, 1-6. John Wiley & Sons, Chichester. J.C. Buckingham, G.E. Gilles, A.-M. Cowell (Eds.).
110. Diamond J. Guns, Germs, and Steel. The Fates of Human Societies 1997, W. W. Norton, New York.
111. Ewald P.W. Evolution of Infectious Disease 1994, Oxford University Press, New York.
112. Holmes T.H., Rahe R.H. The Social Readjustment Rating Scale. Journal of Psychosomatic Research 1967, 2:213-218.
113. Lazarus R.S. Stress and Emotion 1999, Springer, New York.
114. Levine S. Stress: an historical perspective. Handbook of Stress and the Brain 2005, Vol. 15:3-23. Elsevier B.V, Amsterdam. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
115. McEwen B.S. Stress, adaptation and disease: allostasis and allostatic load. Annals of the New York Academy of Sciences 1998, 840:33-44.
116. McMichael T. Human Frontiers, Environments and Disease: Past Patterns, Uncertain Futures 2001, Cambridge University Press, Cambridge.
117. Nesse R.M., Williams G.C. Why We Get Sick: the New Science of Darwinian Medicine 1994, Vintage Books, New York.
118. Sapolsky R.M. Why Zebras Don't Get Ulcers 2004, Henry Holt and Company, New York. 3rd ed.
119. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936, 138:32.
120. Selye H. The general adaptation syndrome and the diseases of adaptation. Journal of Clinical Endocrinology 1946, 6:117-230.
121. Selye H. The Stress of Life 1956, McGraw-Hill, New York.
122. Sterling P., Eyer J. Allostasis-a new paradigm to explain arousal pathology. Handbook of Life Stress, Cognition, and Health 1988, John Wiley & Sons, New York. S. Fisher, J. Reason (Eds.).
123. Taylor S.E., Klein L.C., Lewis B.P., et al. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychological Review 2000, 107:411-429.
124. Biondi M. Effects of stress on immune functions: an overview. Psychoneuroimmunology 2001, Vol. 2. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
125. Buckingham J.C., Cowell A.M., Gilles G.E., et al. The neuroendocrine system: anatomy, physiology, and response to stress. Stress, Stress Hormones and the Immune System 1997, John Wiley & Sons, Chichester. J.C. Buckingham, G.E. Gilles, A.E. Cowell (Eds.).
126. Burns V.E., Edwards K.M., Ring C., Drayson M., Carroll D. Complement cascade activation after acute psychological stress task. Psychosomatic Medicine 2008, 70:387-396.
127. Cerqueira J.J., Almeida O.F.X., Sousa N. The stressed prefrontal cortex: left right!. Brain, Behavior, and Immunity 2008, 22:630-638.
128. Chida Y., Hamer M. Chronic psychosocial factors and acute physiological responses to laboratory-induced stress in healthy populations: a quantitative review of 30 years of investigations. Psychological Bulletin 2008, 134:829-885.
129. Chrousos G.P. Stress and disorders of the stress system. Nature Reviews Endocrinology 2009, 5:374-381.
130. Danese A., Pariante C.M., Caspi A., Taylor A., Poulton R. Childhood maltreatment predicts adult inflammation in a life-course study. Proceedings of the National Academy of Sciences 2007, 104:1319-1324.
131. Danese A., Moffitt T.E., Harrington H.L., et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Archives of Pediatric and Adolescent Medicine 2009, 163:1135-1143.
132. Daruna J.H. Neuroticism predicts variability in the number of circulating leucocytes. Personality and Individual Differences 1996, 20:103-108.
133. Dhabhar F.S. Stress-induced augmentation of immune function-the role of stress hormones, leukocyte trafficking, and cytokines. Brain, Behavior, and Immunity 2002, 16:785-798.
134. Dhabhar F.S. Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009, 16:300-317.
135. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychological Bulletin 2004, 130:355-391.
136. Edwards K.M., Burns V.E., Adkins A.E., Carroll D., Drayson M., Ring C. Meningococcal A vaccination response is enhanced by acute stress in men. Psychosomatic Medicine 2008, 70:147-151.
137. Eggers A.E. Redrawing Papez' circuit: a theory about how acute stress becomes chronic and causes disease. Medical Hypotheses 2007, 69:852-857.
138. Eppel E.S., Lin J., Dhabhar F.S., et al. Dynamics of telomerase activity in response to acute psychological stress. Brain, Behavior, and Immunity 2010, 24:531-539.
139. Fehder W.P., Sacks J., Uvaydova M., Douglas S.D. Substance P: an immune modulator of anxiety. Neuroimmunomodulation 1997, 4:42-48.
140. Flinn M.V. Family environment, stress, and health during childhood. Hormones, Health and Behavior 1999, Cambridge University Press, Cambridge. C. Panter-Brick, C.M. Worthman (Eds.).
141. Foley P., Kirschbaum C. Human hypothalumus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings. Neuroscience and Biobehavioral Reviews 2010, 35:91-96.
142. Glaser R., Kiecolt-Glaser J. Handbook of Human Stress and Immunity 1994, Academic Press, San Diego.
143. Handbook of Stress: Theoretical and Clinical Aspects 1993, Free Press, New York. 2nd ed. L. Goldberger, S. Breznitz (Eds.).
144. Gratton A., Sullivan R.M. Role of prefrontal cortex in stress responsivity. Handbook of Stress and the Brain 2005, Vol. 1:807-817. Elsevier, San Diego. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
145. Handbook of Stress Medicine: an Organ System Approach 1998, CRC Press, Boca Raton. J.R. Hubbard, E.A. Workman (Eds.).
146. Ingram C.D. Pathways and transmitter interactions mediating an integrated stress response. Handbook of Stress and the Brain 2005, Vol. 1:609-639. Elsevier, San Diego. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
147. Ironson G., Cruess D., Kumar M. Immune and neuroendocrine alterations in post-traumatic stress disorder. Psychoneuroimmunology 2007, Vol. 2:531-547. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
148. Kiecolt-Glaser J., Gouin J.-P., Weng N.-P., Malarkey W.B., Beversdorf D.Q., Glaser R. Childhood adversity hightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosomatic Medicine 2011, 73:16-22.
149. Marucha P.T., Egeland C.E. Stress, neuroendocrine hormones, and wound healing: human models. Psychoneuroimmunology 2007, Vol. 2:825-835. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
150. McEwen B.S., Mendelson S. Effects of stress on the neurochemistry and morphology of the brain: counterregulation versus damage. Handbook of Stress: Theoretical and Clinical Aspects 1993, Free Press, New York. 2nd ed. L. Goldberger, S. Breznitz (Eds.).
151. Moons W.G., Eisenberger N.I., Taylor S.E. Anger and fear responses to stress have different biological profiles. Brain, Behavior, and Immunity 2010, 24:215-219.
152. Pace T.W.W., Heim C.M. A short review on the psychoneuroimmunology of post-traumatic stress disorder: from risk factors to medical comorbidities. Brain, Behavior, and Immunity 2011, 25:6-13.
153. Riva M.A. The role of neurotrophic factors in the stress response. Handbook of Stress and the Brain 2005, Vol. 1:665-678. Elsevier, San Diego. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
154. Rosenkranz M.A. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychological Bulletin 2007, 133:1007-1037.
155. Sapolsky R.M. Hormonal correlates of personality and social contexts: from non-human to human primates. Hormones, Health and Behavior 1998, Cambridge University Press, Cambridge. C. Panter-Brick, C.M. Worthman (Eds.).
156. Schedlowski M., Jacobs R., Stratman G., et al. Changes in natural killer cells during acute psychological stress. Journal of Clinical Immunology 1993, 13:119-126.
157. Segerstrom S., Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychological Bulletin 2004, 130:601-630.
158. Handbook of Stress and the Brain 2005, Vols. 1-2. Elsevier, San Diego. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
159. Steptoe A., Hamer M., Chaida Y. The effects of acute psychological stress on circulating inflammatory factors in humans; a review and meta-analysis. Brain, Behavior, and Immunity 2007, 21:901-912.
160. Psychobiology of Stress: A Study of Coping Men 1978, Academic Press, New York. H. Ursin, E. Baade, S. Levine (Eds.).
161. Vellucci S.V. The autonomic and behavioural response to stress. Stress, Stress Hormones and the Immune System 1997, John Wiley & Sons, Chichester. J.C. Buckingham, G.E. Gilles, A.E. Cowell (Eds.).
162. Yuan P.-X., Zhou R., Farzad N., et al. Enhancing resilience to stress: the role of signaling cascades. Handbook of Stress and the Brain 2005, Vol. 1:751-771. Elsevier, San Diego. T. Steckler, N.H. Kalin, J.M.H.M. Reul (Eds.).
163. Zald D.H., Mattson D.L., Pardo J.V. Brain activity in ventromedial prefrontal cortex correlates with individual differences in negative affect. Proceedings of the National Academy of Sciences 2002, 99:2450-2454.
164. Zorilla E., Luborsky L., McKay J.R., et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain, Behavior, and Immunity 2001, 15:199-226.
165. Alcais A., Abel L., Casanova J.-L. Human genetics of infectious disease: between proof of principle and paradigm. Journal of Clinical Investigation 2009, 119:2506-2514.
166. Alexander F., Flagg G.W. The psychosomatic approach. Handbook of Clinical Psychology 1965, McGraw-Hill, New York. B. Wolman (Ed.).
167. Bacigalupe G., Fujiwara T., Selk S., Woo M. Community violence as psychosocial stressor: the case of childhood asthma in Boston. Psychology 2010, 1:27-34.
168. Bieber T. Atopic dermatitis. New England Journal of Medicine 2008, 358:1483-1494.
169. Blackwell J.M., Jamieson S.E., Burgner D. HLA and infectious diseases. Clinical Microbiology Reviews 2009, 22:370-385.
170. Bonneau R.H., Hunzeker J.T. Stress-induced modulation of the immune response to herpes simplex virus infections. Psychoneuroimmunology 2007, Vol. 2:1077-1096. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
171. Brouwer M.C., de Gans J., Heckenberg S.G.B., Zwinderman A.H., van der Poll T., van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infectious Diseases 2009, 9:31-44.
172. Castes M., Hagel I., Palenque M., et al. Immunological changes associated with clinical improvement of asthmatic children subjected to psychosocial intervention. Brain, Behavior, and Immunity 1999, 13:1-13.
173. Chen E., Miller G.E. Stress and inflammation in exacerbations of asthma. Brain, Behavior, and Immunity 2007, 21:993-999.
174. Cohen S., Doyle W.J., Skoner D.P., et al. Social ties and susceptibility to the common cold. Journal of the American Medical Association 1997, 277:1940-1944.
175. Cole S.W., Kemeny M.E. Psychological influences on the progression of HIV infection. Psychoneuroimmunology 2001, Vol. 2:583-612. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
176. Cooke G.S., Hill A.V.S. Genetic susceptibility to human infectious disease. Nature Reviews Genetics 2001, 2:967-977.
177. Cookson W.O.C.M., Moffatt M.F. Asthma: an epidemic in the absence of infection. Science 1997, 275:41-42.
178. Cummings A.J., Knibb R.C., King R.C., Lucas J.S. The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 2010, 65:933-945.
179. De Aranjo G., Van Arsdel P.P., Holmes T.H., Dudley D.L. Life change, coping ability and chronic intrinsic asthma. Journal of Psychosomatic Research 1973, 17:359-363.
180. Doyle W.J., Casselbrant M.L., Li-Korotky H.-S., et al. The interleukin 6-174 C/C genotype predicts greater rhinovirus illness. Journal of Infectious Diseases 2010, 201:199-206.
181. Doyle W.J., Cohen S. Etiology of the common cold: modulating factors. Common Cold 2009, 149-186. Birkhauser Verlag, Basel. R. Eccles, O. Weber (Eds.).
182. Eder W., Ege M.J., von Mutius E. The asthma epidemic. New England Journal of Medicine 2006, 335:2226-2235.
183. Edfors-Lubs M.-L. Allergy in 7000 twin pairs. Acta Allergologica 1971, 26:249-285.
184. Elenkov I.J., Chrousos G.P. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends in Endocrinology and Metabolism 1999, 10:359-368.
185. Ewald P.W. Plaque Time: How Stealth Infections Cause Cancer, Heart Disease, and Other Deadly Ailments 2000, Free Press, New York.
186. Fahdi I.E., Gaddam V., Garza L., et al. Inflammation, infection, and atherosclerosis. Brain, Behavior, and Immunity 2003, 17:238-244.
187. Faleide A.O., Unger S., Watten R.G. Psychosocial factors in bronchial asthma and allergy in childhood: a prospective study. Psychosomatic Medicine: Past and Future 1987, Plenum Press, New York. G.N. Christodoulou (Ed.).
188. Feaster D.J., Goodkin K., Blaney N.T., et al. Longitudinal psychoneuroimmunologic relationship in the natural history of HIV-1 infection: the stressor-support-coping model. Psychoneuroimmunology: Stress, Mental Disorders, and Health 2000, American Psychiatric Press, Washington, DC. K. Goodkin, A.P. Visser (Eds.).
189. Friedman H.S., Booth-Kewley S. The 'disease-prone-personality': a meta-analytic view of the construct. American Psychologist 1987, 42:539-555.
190. Funkenstein D.H. The relationship of experimentally produced asthmatic attack to certain acute life stresses. Journal of Allergy 1953, 24:11-17.
191. Gregerson M.B. The curious 2000-year case of asthma. Psychosomatic Medicine 2000, 62:816-827.
192. Gustafsson P.A., Bjorksten G., Kjellman N.I. Family dysfunction in asthma: a prospective study of illness development. Journal of Pediatrics 1994, 125:493-498.
193. Haczku A., Panittieri R. Social stress and asthma: the role of corticosteroid insensitivity. Journal of Allergy and Clinical Immunology 2010, 125:550-558.
194. Infectious Diseases: a Treatise of Infectious Processes 1994, J.B. Lippincott Co, Philadelphia. 5th ed. P.D. Hoeprich, M.C. Jordan, A.R. Ronald (Eds.).
195. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain, Behavior, and Immunity 2002, 16:1-16.
196. Kemeny M.E. Stressful events, psychological responses and progression of HIV infection. Handbook of Human Stress and Immunity 1994, Academic Press, San Diego. R. Glaser, J. Kiecolt-Glaser (Eds.).
197. Kop W.J., Cohen N. Psychosocial risk factors and immune system involvement in cardiovascular disease. Psychoneuroimmunology 2001, Vol. 2:525-544. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
198. Kozyrskyj A.L., Ernst P., Becker A.B. Increased risk of childhood asthma from antibiotic use in early life. Chest 2007, 131:1753-1759.
199. Maizels R.M., Allen J.E. Eosinophils forestall obesity. Science 2011, 332:186-187.
200. Marshall G.D., Roy S.R. Stress and allergic diseases. Psychoneuroimmunology 2007, Vol. 2:799-824. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
201. McDonals B., Pittman K., Menezes G.B., et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
202. McKeever T.M., Lewis S.A., Smith C., et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. Journal of Allergy and Clinical Immunology 2002, 109:43-50.
203. Meijer A.M., Griffioen R.W., van Nierop J.C., et al. Intractable or uncontrollable asthma: psychosocial factors. Journal of Asthma 1995, 32:265-274.
204. Mitzgard J.P. Acute lower respiratory tract infection. New England Journal of Medicine 2008, 358:716-727.
205. Moller M., Gravenor M.B., Roberts S.E., Sun D., Gao P., Hopkin J.M. Genetic haplotypes of Th-2 immune signalling link allergy to enhanced protection to parasitic worms. Human Molecular Genetics 2007, 16:1828-1836.
206. Motsinger A.A., Haas D.W., Hulgan T., Ritchie M.D. Human genomic association studies: a primer for infectious diseases specialists. Journal of Infectious Diseases 2007, 195:1737-1744.
207. Infectious Disease Epidemiology: Theory and Practice 2001, Aspen Publishers, Gaithersburg. K.E. Nelson, C.M. Williams, N.M.H. Graham (Eds.).
208. Padur J.S., Rapoff M.A., Houston B.K., et al. Psychosocial adjustment and the role of functional status for children with asthma. Journal of Asthma 1995, 32:345-353.
209. Pedersen A., Zachariae R., Bovbjerg D.H. Influence of psychological stress on upper respiratory infection-a meta-analysis of prospective studies. Psychosomatic Medicine 2010, 72:823-832.
210. Petersen L., Andersen P.K., SØrensen T.I.A. Genetic influences on incidence and case-fatality of infectious disease. PLoS ONE 2010, 5(5). e10603.doi:10.1371/journal.pone.0010603.
211. Pinheiro P., Mathers C.D., Kramer A. The global burden of infectious diseases. Modern Infectious Disease Epidemiology: Concepts, Methods, Mathematical Models, and Public Health 2010, 3-22. Springer, New York. A. Kramer, M. Kretzschmar, K. Krickeberg (Eds.).
212. Schneiderman N., Antoni M., Ironson G., et al. HIV-1, immunity, and behavior. Handbook of Human Stress and Immunity 1994, Academic Press, San Diego. R. Glaser, J. Kilcolt-Glaser (Eds.).
213. Sevin C.M., Peebles R.S. Infections and asthma: new insights into old ideas. Clinical and Experimental Allergy 2010, 40:1142-1154.
214. Shuman E.K. Global climate change and infectious diseases. International Journal of Occupational and Environmental Medicine 2011, 2:11-19.
215. Sloan E., Collado-Hidalgo A., Cole S. Psychobiology of HIV infection. Psychoneuroimmunology 2007, Vol. 2:1053-1076. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
216. Spahn J.D., Szefler S.J. Childhood asthma: new insights into management. Journal of Allergy and Clinical Immunology 2002, 109:3-13.
217. Steptoe A., Brydon L., Cole S. Psychosocial factors and coronary heart disease: the role of psychoneuroimmunological processes. Psychoneuroimmunology 2007, Vol. 2:945-974. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
218. Telfer S., Lambin X., Birtles R., et al. Species interactions in a parasite community drive infection risk in a wildlife population. Science 2010, 330:243-246.
219. Theoharides T.C. Mast cells and stress-a psychoneuroimmunological perspective. Journal of Clinical Psychopharmacology 2002, 22:103-107.
220. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nature Reviews Immunology 2008, 8:169-182.
221. Vogel G. Missing gene takes mice's breath away. Science 2002, 295:253.
222. Weiner H., Shapiro A.P. Helicobacter pylori, immune function, and gastric lesions. Psychoneuroimmunology 2001, Vol. 2:671-686. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
223. Wjst M., Roell G., Dold S., et al. Psychosocial characteristics of asthma. Journal of Clinical Epidemiology 1996, 49:461-466.
224. Wright R.J. Epidemiology of stress and asthma: from constricting communities and fragile families to epigenetics. Immunology and Allergy Clinics of North America 2011, 31:19-39.
225. Zorrilla E.P., McKay J.R., Luborsky L., Schmidt K. Relation of stressors and depressive symptoms to clinical progression of viral illness. American Journal of Psychiatry 1996, 153:626-635.
226. Clinical Oncology 2000, Churchill Livingstone, New York. 2nd ed. M.D. Abeloff, J.O. Armitage, A.S. Lichter, J.E. Niederhuber (Eds.).
227. Albert M.L., Darnell R.B. Paraneoplastic neurological degenerations: keys to tumour immunity. Nature Reviews Cancer 2004, 4:36-44.
228. Andersen B.L., Kiecolt-Glaser J.K., Glaser R. A biobehavioral model of cancer stress and disease course. American Psychologist 1994, 49:389-404.
229. Aranow C., Diamond B., MacKay M. Systemic lupus erythematosu. Clinical Immunology Principles and Practice 2008, 749-766. Elsevier/Mosby, Philadelphia. 3rd ed. R.R. Rich, T.A. Flisher, W.T. Shearer, H.W. Schroeder, A.J. Frew, C.M. Weyand (Eds.).
230. Ascherio A., Munger K.L. Epstein-Barr virus and multiple sclerosis: epidemiological evidence. Clinical and Experimental Immunology 2010, 160:120-124.
231. Boesen E.H., Johansen C. Impact of psychotherapy on cancer survival: time to move on. Current Opinion in Oncology 2008, 20:372-377.
232. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmunity Reviews 2010, 9:A277-A287.
233. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
234. Chida Y., Hamer M., Wardle J., Steptoe A. Do stress related psychosocial factors contribute to cancer incidence and survival. Nature Clinical Practice Oncology 2008, 5:466-475.
235. Classen C.C., Kramer H.C., Blasey C., et al. Supportive-expressive therapy for primary breast cancer patients: a randomized prospective multicenter trial. Psycho-Oncology 2008, 17:438-447.
236. Cohen I.R. Tending Adam's Garden: Evolving the Cognitive Immune Self 2000, Academic Press, San Diego.
237. Cohen M.J.M., Kunkel E.S., Levenson J.L. Association between psychosocial stress and malignancy. Handbook of Stress Medicine: an Organ System Approach 1998, CRC Press, Boca Raton. J.R. Hubbard, E.A. Workman (Eds.).
238. Cooper G.S., Bynum M.L.K., Somers E.C. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity 2009, 33:197-207.
239. Cortese I., McFarland H.F. Multiple sclerosis. Clinical Immunology Principles and Practice 2008, 963-975. Elsevier/ Mosby, Philadelphia. 3rd ed. R.R. Rich, T.A. Flisher, W.T. Shearer, H.W. Schroeder, A.J. Frew, C.M. Weyand (Eds.).
240. Cosgrove L., Shi L., Creasey D.E., Anaya-McKivergan M., Myers J.A., Huybrechts K.F. Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS ONE 2011, 4:e18210.
241. Cousins N. Anatomy of an Illness 1979, W. W. Norton, New York.
242. Coyne J.C., Stefanek M., Palmer S.C. Psychotherapy and survival from cancer: the conflict between hope and evidence. Psychological Bulletin 2007, 133:367-394.
243. Darnall B.D., Suarez E.C. Sex and gender in psychoneuroimmunology reasearch: past, present, and future. Brain, Behavior, and Immunity 2009, 23:595-604.
244. Dube S.R., Fairweather D., Pearson W.S., Felitti V.J., Anda R.F., Croft J.B. Cumulative childhood stress and autoimmune diseases in adults. Psychosomatic Medicine 2009, 71:243-250.
245. Fawzy F.I., Fawzy N.W., Hyun C.S., et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state or recurrence and survival six years later. Archives of General Psychiatry 1993, 50:681-689.
246. Foley F.W., Miller A.H., Trangott V., et al. Psychoimmunological dysregulation in multiple sclerosis. Psychosomatics 1988, 29:398-403.
247. Fox B.H. Psychosocial factors in cancer incidence and prognosis. Psycho-Oncology 1999, Oxford University Press, New York. J.C. Holland (Ed.).
248. Gidron Y., Ronson A. Psychosocial factors, biological mediators, and cancer prognosis: a new look at an old story. Current Opinion in Oncology 2008, 20:386-392.
249. Goodin D.S., Ebers G.C., Johnson K.P., et al. The relationship of MS to physical trauma and psychological stress: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999, 52:1737-1745.
250. Goodwin P.J., Leszcz M., Ennis M., et al. The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine 2001, 345:1719-1726.
251. Greaves M. Cancer: the Evolutionary Legacy 2002, Oxford University Press, Oxford.
252. Hall S.S. A Commotion in the Blood: Life, Death, and the Immune System 1997, Henry Holt and Co, New York.
253. Hamer M., Chida Y., Molley G.J. Psychological distress and cancer mortality. Journal of Psychosomatic Research 2009, 66:255-258.
254. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
255. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer Journal for Clinicians 2011, doi: 10.33222/caac.20107.
256. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer Journal for Clinicians 2010, doi: 10.3322/caac.20073.
257. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M.H. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clinical Journal of Immunology and Immunopathology 1997, 84:223-243.
258. Justice A. Review of the effects of stress on cancer in laboratory animals: importance of time of stress application and type of tumor. Psychological Bulletin 1985, 98:108-138.
259. Kivity S., Agmon-Levin N., Blank M., Shoenfeld Y. Infections and autoimmunity-friends or foes. Trends in Immunology 2009, 30:409-414.
260. Textbook of the Autoimmune Diseases 2000, Lippincott Williams & Wilkins, Philadelphia. R.G. Lakita, N. Chiarazzi, W.H. Reeves (Eds.).
261. Levy S.M. Behavior and Cancer 1985, Jossey-Bass, San Francisco.
262. Levy S.M., Herberman R.B., Maluish A.M., et al. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychology 1985, 4:99-113.
263. Ligier S., Sternberg E.M. The neuroendocrine system and rheumatoid arthritis: focus on the hypothalamo-pituitary-adrenal axis. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
264. Lutgendorf S.K., Costanzo E.K., Siegel S.D. Psychosocial influences in oncology: an expanded model of biobehavioral mechanisms. Psychoneuroimmunology 2007, Vol. 2:869-895. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
265. MacKie R.M., Reid R., Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. New England Journal of Medicine 2003, 348:567-568.
266. McKay C.J., Agarwal S.K. Stress and autoimmunity. Immunology and Allergy Clinics of North America 2011, 31:1-18.
267. Michael Y.L., Carlson N.E., Chlebowski R.T., et al. Influence of stressors on breast cancer incidence in the women's health initiative. Health Psychology 2009, 28:137-146.
268. Nakaya N., Bidstrup P.E., Sakito-Nakaya K., et al. Personality traits and cancer risk and survival based on Finnish and Swedish registry data. American Journal of Epidemiology 2010, 172:377-385.
269. Osborne R.H., Sali A., Aaronson N.K., Elsworth G.R., Mdzewski B., Sinclair A.J. Immune function and adjustment style: do they predict survival in breast cancer. Psycho-Oncology 2004, 13:199-210.
270. Pearce J.M.S. Historical descriptions of multiple sclerosis. European Neurology 2005, 54:49-53.
271. Prat A., Antel J.P. Neuroendocrine influences on autoimmune disease: multiple sclerosis. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
272. Rimon R. A psychosomatic approach to rheumatoid arthritis: a clinical study of 100 female patients. Acta Rheumatologica Scandinavica 1969, 13:1-154.
273. Rogers M.P., Brooks E.B. Psychosocial influences, immune function and the progression of autoimmune disease. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
274. The Autoimmune Disease 1998, Academic Press, San Diego. 3rd ed. N.R. Rose, I.R. Mackay (Eds.).
275. Schiffer R.B., Hoffman S.A. Behavioral sequelae of autoimmune disease. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
276. Schreiber R.D., Old L.J., Smyth M.J. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011, 331:1565-1570.
277. Solomon G.F. Emotional and personality factors in the onset and course of autoimmune disease, particularly rheumatoid arthritis. Psychoneuroimmunology 1981, Academic Press, New York. R. Ader (Ed.).
278. Spiegel D., Bloom J.R., Kraemer H.C., Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2:888-891.
279. Spiegel D., Butler L.D., Giese-Davis J., et al. Effect of supportive-expressive group therapy on survival of patients with metastatic breast cancer: a randomized prospective trial. Cancer 2007, 110:1130-1137.
280. Stein S., Speigel D. Psychoneuroimmune and endocrine effects on cancer progression. Psychoneuroimmunology: Stress, Mental Disorders, and Health 2000, American Psychiatric Press, Washington, DC. K. Goodkin, A.P. Visser (Eds.).
281. Stommel M., Given B.A., Given C.W. Depression and functional status as predictors of death among cancer patients. Cancer 2002, 94:2719-2727.
282. Stratton M.R. Exploring the genomes of cancer cells: progress and promise. Science 2011, 331:1553-1558.
283. Surtees P.G., Wainwright N.W.J., Luben R.N., Khaw K.-T., Bingham S.A. No evidence that social stress is associated with cancer incidence. Breast Cancer Research and Treatment 2010, 120:169-174.
284. Turner-Cobbs J.M., Sephton S.E., Spiegel D. Psychosocial effects on immune function and disease progression in cancer: human studies. Psychoneuroimmunology 2001, Vol. 2. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
285. Van der Pompe G. Neoadjuvant immunostimulation in oncologic surgery. Psychoneuroimmunology: Stress, Mental Disorders, and Health 2000, American Psychiatric Press, Washington, DC. K. Goodkin, A.P. Visser (Eds.).
286. Vineis P., Matullo G., Manuguerra M. An evolutionary paradigm for carcinogenesis. Journal of Epidemiology and Community Health 2003, 57:89-95.
287. Visser A.P., Goodkin K., Vingerholts A.J.J.M., et al. Cervical cancer: psychosocial and psychoneuroimmunologic issues. Psychoneuroimmunology: Stress, Mental Disorders, and Health 2000, American Psychiatric Press, Washington, DC. K. Goodkin, A.P. Visser (Eds.).
288. Weiner H. Social and psychological factors in autoimmune disease. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
289. Whitacre C.C., Cummings S.O., Griffin A.C. The effects of stress on autoimmune disease. Handbook of Human Stress and Immunity 1994, Academic Press, San Diego. R. Glaser, J.K. Kilcolt-Glaser (Eds.).
290. Wilder R.L., Elenkov I.J. Ovarian and sympathoadrenal hormones, pregnancy, and autoimmune diseases. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
291. Xavier R.J., Rioux J.D. Genome-wide association studies: a new window into immune-mediated diseases. Nature Reviews Immunology 2008, 8:631-643.
292. Zautra A.J., Okun M.A., Robinson S.E., et al. Life stress and lymphocyte alterations among patients with rheumatoid arthritis. Health Psychology 1989, 8:1-14.
293. Allen A.J., Leonard H.L., Swedo S.E. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:307-311.
294. Andreasen N.C. Understanding the causes of schizophrenia. New England Journal of Medicine 1999, 340:645-647.
295. Anisman H., Merali Z. Cytokines, stress, and depressive illness. Brain, Behavior, and Immunity 2002, 16:513-524.
296. Arbuckle M.R., McClain M.T., Rubertone M.V., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. New England Journal of Medicine 2003, 349:1526-1533.
297. Atkinson J.H., Heaton R.K., Patterson T.L., et al. Two-year prospective study of major depressive disorder in HIV-infected men. Journal of Affective Disorders 2008, 108:225-234. The HNRC Group.
298. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity 2011, 25:40-45.
299. Ashwood P., Krakowiak P., Hertz-Picciotto I., Hansen R., Pessah I., Van de Water J. Altered T cell responses in children with autism. Brain, Behavior, and Immunity 2011, 25:840-849.
300. Banks W.A., Lynch J.L., Price T.O. Cytokines and the blood brain barrier. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 3-17. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
301. Baumann H., Gauldie J. The acute phase response. Immunology Today 1994, 15:74-80.
302. Bennett R.M. Fibromyalgia. Textbook of Autoimmune Diseases 2000, Lippincott Williams & Wilkins, Philadelphia. R.G. Lahita (Ed.).
303. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. American Journal of Psychiatry 2010, 167:261-280.
304. Brown A.S., Hooton J., Schaefer C.A., et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. American Journal of Psychiatry 2004, 161:889-895.
305. Buka S.L., Tsuang M.T., Fuller-Torrey E., et al. Maternal cytokine levels during pregnancy and adult psychosis. Brain, Behavior, and Immunity 2001, 15:411-420.
306. Cairns V., Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. International Journal of Epidemiology 2005, 34:1340-1345.
307. Camara E.G., Chelune G.J. Paraneoplastic limbic encephalopathy. Brain, Behavior, and Immunity 1987, 1:349-355.
308. Capuron L., Hauser P., Hinze-Selch D., et al. Treatment of cytokine induced depression. Brain, Behavior, and Immunity 2002, 16:575-580.
309. Capuron L., Miller A., Irwin M.R. Psychoneuroimmunology of depressive disorder: mechanisms and clinical implications. Psychoneuroimmunology 2007, Vol. 1:509-530. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
310. Chang Q., Szegedi S.S., O'Connor J.C., Dantzer R., Kelley K.W. Cytokine-induced sickness behavior and depression. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 145-181. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
311. Chen R.T., DeStefano F. Vaccine adverse events: causal or coincidental. Lancet 1998, 351:611-612.
312. Crnic L.S. Behavioral consequences of virus infection. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
313. Crow M.K. Superantigens. Textbook of Autoimmune Diseases 2000, Lippincott Williams & Wilkins, Philadelphia. R.G. Lahita (Ed.).
314. Dalmau J., Tuzun E., Wu H-y, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Annals of Neurology 2007, 61:25-36.
315. Dantzer R. Cytokine induced sickness behavior: where do we stand. Brain, Behavior, and Immunity 2001, 15:7-24.
316. Dantzer R., Bluthe R.-M., Castanon N., et al. Cytokines, sickness behavior, and depression. Psychoneuroimmunology 2007, Vol. 1:281-318. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
317. Darnell R.B. The importance of defining the paraneoplastic neurologic disorders. New England Journal of Medicine 1999, 340:1831-1832.
318. Darnell R.B., Posner J.B. Paraneoplastic syndromes involving the nervous system. New England Journal of Medicine 2003, 349:1543-1554.
319. De Beaurepaire R. Questions raised by the cytokine hypothesis of depression. Brain, Behavior, and Immunity 2002, 16:610-617.
320. de Magistris L., Familiari V., Pascotto A., et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. Journal of Pediatric Gastroenterology & Nutrition 2010, 51:418-424.
321. Denicoff K.D., Rubinow D.R., Papa M.Z., et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine activated killer cells. Annals of Internal Medicine 1987, 1017:293-300.
322. Diamond B., Huerta P.T., Mina-Osorio P., Kowal C., Volpe B.T. Losing your nerves Maybe it's the antibodies. Nature Reviews Immunology 2009, 9:449-456.
323. Dowlati Y., Herrmann N., Swardfager W., et al. A meta-analysis of cytokines in major depression. Biological Psychiatry 2010, 67:446-457.
324. Drzyzga L., Obuchowicz E., Marcinowska A., Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain, Behavior, and Immunity 2006, 20:532-545.
325. Duggan P.J., Maalouf E.F., Watts T.L., et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001, 358:1699-1700.
326. Fallon B.A., Nields J.A. Lyme disease: a neuropsychiatric illness. American Journal of Psychiatry 1994, 151:1571-1583.
327. Feder H.M., Johnson B.J.B., O'Connell S., Shapiro E.D., Steere A.C., Wormser G.P. A critical appraisal of "chronic Lyme disease". New England Journal of Medicine 2007, 357:1422-1430. The Ad Hoc International Lyme Disease Group.
328. Fu Z.F., Jackson A.C. Neuronal dysfunction and death in rabies virus infection. Journal of NeuroVirology 2005, 11:101-106.
329. Fuller-Torrey E., Yolken R.H. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both. Brain, Behavior, and Immunity 2001, 15:401-410.
330. Ganguli R., Brar J.S., Rabin B.S. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harvard Review of Psychiatry 1994, 2:70-83.
331. Giedd J.N., Rapoport J.L., Leonard H.L., et al. Case study: acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35:913-915.
332. Gonzalez-Scarano F., Martin-Garcia J. The neuropathogenesis of AIDS. Nature Reviews Immunology 2005, 5:69-81.
333. Goodkin K., Shapshak P., Fujimura R.K., et al. Immune function brain and HIV-1 infection. Psychoneuroimmunology Stress, Mental Disorders, and Health 2000, American Psychiatric Press, Washington, DC. K. Goodkin, A.P. Visser (Eds.).
334. Chronic Fatigue and Related Immune Deficiency Syndromes 1993, American Psychiatric Press, Washington, DC. P.J. Goodnick, N.G. Klimas (Eds.).
335. Grigoleit J.-S., Oberbeck J.R., Lichte P., et al. Lipopolysaccharide-induced experimental immune activation does not impair memory function in humans. Neurobiology of Learning and Memory 2010, 94:561-567.
336. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biological Psychiatry 2009, 66:407-414.
337. Hart B.L. Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews 1988, 12:123-137.
338. Hart D.J., Heath R.G., Sautter F.J., et al. Antiretroviral antibodies: implication for schizophrenia, schizophrenia spectrum disorders, and bipolar disorder. Biological Psychiatry 1998, 45:704-714.
339. Hinze-Selch D., Pollmächer T. In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for future research. Brain, Behavior, and Immunity 2001, 15:282-318.
340. Hoffman S.A., Sakic B. Autoimmunity and brain dysfunction. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 341-381. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
341. Hooper D.C. The role of immune responses in the pathogenesis of rabies. Journal of NeuroVirology 2005, 11:88-92.
342. Irwin M. Depression and immunity. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
343. Irwin M. Effects of sleep and sleep loss on immunity and cytokines. Brain, Behavior, and Immunity 2002, 16:503-512.
344. Johnson R.T. Viral Infections of the Nervous System 1998, Lippincott-Raven Press, Philadelphia. 2nd ed.
345. Kendall-Tackett K. Treatments for depression that lower inflammation: additional support for an inflammatory etiology of depression. The Psychoneuroimmunology of Chronic Disease 2010, 219-242. APA Press, Washington, DC. K. Kendall-Tackett (Ed.).
346. Kent S., Bluthé R.-M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 1992, 13:24-28.
347. Kinney D.K., Hintz K., Shearer E.M., et al. A unifying hypothesis of schizophrenia: abnormal immune system development may help explain roles of prenatal hazards, post-pubertal onset, stress, genes, climate, infections, and brain dysfunction. Medical Hypothesis 2010, 74:555-563.
348. Klimas N.G., Salvato F.R., Morgan R., Fletcher M.A. Immunologic abnormalities in chronic fatigue syndrome. Journal of Clinical Microbiology 1990, 28:1403-1410.
349. Kohman R.A., Hash-Converse J.M., Kusnecov A.W. Effect of systemic challenge with bacterial toxins on behaviors relevant to mood, anxiety and cognition. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 183-208. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
350. Lakhan S.E., Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutrition & Metabolism 2010, 7:79.
351. Leslie D.L., Kozma L., Martin A., et al. Neuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children. Journal of the American Academy of Child and Adolescent Psychiatry 2008, 47:1166-1172.
352. Libbey J.E., Sweeten T.L., McMahon W.M., Fujinami R.S. Autistic disorder and viral infections. Journal of NeuroVirology 2005, 11:1-10.
353. Lichtenstein P., Carlstrom E., Rastam M., Gillberg C., Anckarsater H. The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. American Journal of Psychiatry 2010, 167:1357-1363.
354. Machon R.A., Mednick S.A., Huttunen M.O. Adult major affective disorder after prenatal exposure to an influenza epidemic. Archives of General Psychiatry 1997, 54:322-328.
355. Maes M., Van der Planken M., Stevens W.J., et al. Leukocytosis, monocytosis, and neutrophilia: hallmarks of severe depression. Journal of Psychiatry Research 1992, 26:125-134.
356. Maier S.F., Watkins L.R. Cytokines for psychologists: implications for bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review 1998, 105:83-107.
357. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neuroscience and Biobehavioral Reviews 2009, 33:355-366.
358. Meijer A., Zakay-Rones Z., Morag A. Post-influenzal psychiatric disorder in adolescents. Acta Psychiatrica Scandinavica 1988, 78:176-181.
359. Menninger K.A. The schizophrenic syndrome as a product of acute infectious disease. Journal of Neurology and Psychiatry 1928, 20:464-481.
360. Merrill J.E., Murphy S.P. Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species. Brain, Behavior and Immunity 1997, 11:245-263.
361. Miller A.H. Depression and immunity: a role for T cells. Brain, Behavior, and Immunity 2010, 24:1-8.
362. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
363. Mortensen P.B., Pedersen C.B., Westergaard T., et al. Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine 1999, 340:603-608.
364. Muller N., Ackenheil M. The immune system and schizophrenia. Stress, the Immune System and Psychiatry 1995, John Wiley & Sons, New York. B. Leonard, K. Miller (Eds.).
365. Muller N., Schwarz M.J. Cytokines, immunity and schizophrenia with emphasis on underlying neurochemical mechanisms. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 307-325. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
366. Murphy T.K., Kurlan R., Leckman J. The immunobiology of Tourette's disorder, pediatric autoimmune neuropsychiatric disorders associated with Streptococcus, and related disorders: a way forward. Journal of Child and Adolescent Psychopharmacology 2010, 20:317-331.
367. Narayan O., Herzog S., Frese K., Rott R. Behavioral disease in rats caused by immunopathological responses to persistent borna virus in the brain. Science 1983, 220:1401-1403.
368. Newschaffer C.J., Croen L.A., Daniels J., et al. The epidemiology of autism spectrum disorders. Annual Review of Public Health 2007, 28:235-258.
369. Pearce B.D. Viruses and psychiatric disorders. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 383-410. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
370. Perry S., Müller F. Psychiatric aspects of systemic lupus erythematosus. Systemic Lupus Erythematosus 1992, Churchill Livingstone, New York. 2nd ed. R.G. Lahita (Ed.).
371. Rapaport M.H., Miller N. Immunological states associated with schizophrenia. Psychoneuroimmunology 2001, Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
372. Reed W.P., Johnson D.R., Davis L.E. Nervous system infection. Infectious Disease in Emergency Medicine 1998, Lippincott-Raven Press, Philadelphia. 2nd ed. J.C. Brillman, R.W. Quenzer (Eds.).
373. Ronald A., Pennell C.E., Whitehouse A.J.O. Prenatal maternal stress associated with ADHD and autistic traits in early childhood. Frontiers in Psychology 2011, 1(223):1-8.
374. Rothermundt M., Arolt V. Schizophrenia and immunity. Psychoneuroimmunology 2007, Vol. 1:563-577. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
375. Rothermundt M., Arolt V., Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain, Behavior, and Immunity 2001, 15:319-339.
376. Rzhetsky A., Wajngurt D., Park N., Zheng T. Probing genetic overlap among complex human phenotypes. Proceedings of the National Academy of Sciences 2007, 104:11694-11699.
377. Schleifer S.J. Immunity and depression: a clinical perspective. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 287-305. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
378. Schnell M.J., McGettigan J.P., Wirblich C., Papaneri A. The cell biology of rabies virus: using stealth to reach the brain. Nature Reviews Microbiology 2010, 8:51-61.
379. Schwarz M.J., Chiang S., Müller N., Ackenheil M. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain, Behavior, and Immunity 2001, 15:340-370.
380. Scott C.A., Rossiter J.P., Andrew R.D., Jackson A.C. Structural abnormalities in neurons are sufficient to explain the clinical disease and fatal outcome of experimental rabies in yellow fluorescent protein-expressing transgenic mice. Journal of Virology 2008, 82:513-521.
381. Singh V.K., Warren R.P., Odell J.D., Coles P. Changes in soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic kids. Clinical Immunology and Immunopathology 1991, 61:448-455.
382. Smith R.S. Is schizophrenia caused by excessive production of interleukin-2 and interleukin-2 receptors by gastrointestinal lymphocytes. Medical Hypotheses 1991, 34:225-229.
383. Smith R.S. The immune system is a key factor in the etiology of psychosocial disease. Medical Hypotheses 1991, 34:49-57.
384. Solomon G.F. Immunologic abnormalities in mental illness. Psychoneuroimmunology 1981, Academic Press, New York. R. Ader (Ed.).
385. Sommershof A., Aichinger H., Engler H., et al. Substantial reduction in naive and regulatory T cells following traumatic stress. Brain, Behavior, and Immunity 2009, 23:1117-1124.
386. Swedo S.E. Sydenham's chorea: a model for childhood autoimmune neuropsychiatric disorders. Journal of the American Medical Association 1994, 272:1788-1791.
387. Swedo S.E., Grant P.J. Annotation: PANDAS: a model for human autoimmune disease. Journal of Child Psychology and Psychiatry 2005, 46:227-234.
388. Swedo S.E., Leonard H.L., Mittleman B.B., et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. American Journal of Psychiatry 1997, 154:110-112.
389. Tuomanen E. Breaching the blood brain barrier. Scientific American, February 1993, 80-84.
390. Uthgenannt D., Schoolmann D., Pietrowsky R., et al. Effects of sleep on the production of cytokines in humans. Psychosomatic Medicine 1995, 57:97-104.
391. van't Land H., Verdurmen J., ten Have M., van Dorsselaer S., Beekman A., de Graaf R. The association between arthritis and psychiatric disorders; results from a longitudinal population-based study. Journal of Psychosomatic Research 2010, 68:187-193.
392. Vilensky J.A., Foley P., Gilman S. Children and encephalitis lethargica: a historical review. Pediatric Neurology 2007, 37:79-84.
393. Volz R., Gultekin S.H., Rosenfeld M.R., et al. A serologic marker of paraneoplastic limbic and brain stem encephalitis in patients with testicular cancer. New England Journal of Medicine 1999, 340:1788-1795.
394. Wakefield A.J., Murch S.H., Anthony A., et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet 1998, 351:637-641.
395. Watkins L.R., Wieseler-Frank J., Hutchinson M.R., et al. Neuroimmune interactions and pain: the role of immune and glial cells. Psychoneuroimmunology 2007, Vol. 1:393-427. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
396. Weiss L.A., Shen Y., Korn J.M., Licinio J., et al. Association between microdeletion and microduplication at 16p11.2 and autism. New England Journal of Medicine 2008, 358:667-675. for the Autism Consortium.
397. Wong M.-L., Dong C., Maestre-Mesa J., Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Molecular Psychiatry 2008, 13:800-812.
398. Yolken R.H., Torrey E.F. Viruses, schizophrenia and bipolar disorder. Clinical Microbiological Reviews 1995, 8:131-145.
399. Yolken R.H., Torrey E.F. Are some cases of psychosis caused by microbial agents A review of the evidence. Molecular Psychiatry 2008, 13:470-479.
400. Zalcman S.S., Woodruff R.T., Mohla R., Siegel A. Neurochemical and behavioral changes induced by interleukin-2 and soluble interleukin-2 receptors. The Neuroimmunological Basis of Behavior and Mental Disorders 2009, 261-284. Springer, New York. A. Siegel, S.S. Zalcman (Eds.).
401. Antoni M.H., Schneiderman N., Penedo F. Behavioral interventions: immunologic mediators and disease outcomes. Psychoneuroimmunology 2007, Vol. 1:675-703. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
402. Barrientos R.M. Voluntary exercise as an anti-inflammatory theraputic. Brain, Behavior, and Immunity 2011, 25:1061-1062.
403. Benham G. Sleep: an important factor in stress-health models. Stress and Health 2010, 26:204-214.
404. Berkman L.F., Glass T., Brissette I., Seeman T.E. From social integration to health: Durkheim in the new millennium. Social Science & Medicine 2000, 51:843-857.
405. Booth R.J., Petrie K.J., Pennebacker J.W. Changes in circulating lymphocyte numbers following emotional disclosure: evidence of buffering. Stress Medicine 1997, 13:23-29.
406. Brady H., Brady D. The Placebo Response 2000, Harper Collins, New York.
407. Calder P.C. Polyunsaturated fatty acids, inflammation, and inflammatory diseases. The Psychoneuroimmunology of Chronic Disease 2010, 77-109. APA Press, Washington, DC. K. Kendall-Tackett (Ed.).
408. Campbell T.C., Campbell T.M. The China Study: Startling Implications for Diet, Weight Loss, and Long-Term Health 2004, Benbella Books, Dallas, TX.
409. Carlson L.E., Speca M., Faris P., Patel K.D. One year pre-post intervention follow-up of psychological, immune, endocrine and blood pressure outcomes of mindfulness-based stress reduction (MBSR) in breast and prostate cancer outpatients. Brain, Behavior, and Immunity 2007, 21:1038-1049.
410. Carver C.S., Scheier M.F., Segerstrom S.C. Optimism. Clinical Psychology Review 2010, 30:879-889.
411. Christensen A.J., Edwards D.L., Wiebe J.S., et al. Effect of verbal self-disclosure on natural killer cell activity: moderating influence of cynical hostility. Psychosomatic Medicine 1996, 58:150-155.
412. Davidson R.J., Kabat-Zinn J., Schumacher J., et al. Alterations in brain and immune function produced by mindfulness meditation. Psychosomatic Medicine 2003, 65:564-570.
413. Ditzen B., Neumann I.D., Bodenmann G., et al. Effects of different kinds of couple interaction on cortisol and heart rate responses to stress in women. Psychoneuroendocrinology 2007, 32:565-574.
414. Fawzy F.I., Kemeny M.E., Fawzy N.W., et al. A structured psychiatric intervention for cancer patients: changes over time in immunological measures. Archives of General Psychiatry 1990, 47:729-735.
415. Faymonville M.-E., Boly M., Laureys S. Functional neuroanatomy of the hypnotic state. Journal of Physiology Paris 2006, 99:463-469.
416. Field T. Touch for socioemotional and physical well-being: a review. Developmental Review 2010, 30:367-383.
417. Fontana L. Neuroendocrine factors in the regulation of inflammation: excessive adiposity and calorie restriction. Experimental Gerontology 2009, 44:41-45.
418. Frattaroli J. Experimental disclosure and its moderators: a meta-analysis. Psychological Bulletin 2006, 132:823-865.
419. Green M.L., Green R.G., Santoro W. Daily relaxation modifies serum and salivary immunoglobulin and psychophysiologic symptoms severity. Biofeedback and Self-Regulation 1998, 13:187-199.
420. Guest C.B., Gao Y., O'Connor J.C., Freund G.G. Obesity and immunity. Psychoneuroimmunology 2007, Vol. 2:993-1011. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
421. Hall N.R.S., O'Grady M. Psychosocial interventions and immune function. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
422. Halley F.M. Self-regulation of the immune system through biobehavioral strategies. Biofeedback and Self-Regulation 1991, 16:55-74.
423. Harrington A. The Placebo effect: an Interdisciplinary Exploration 1997, Harvard University Press, Cambridge.
424. Hewson-Bower B., Drummond P.D. Secretory immunoglobulin A increases during relaxation in children with and without recurrent respiratory tract infections. Journal of Developmental and Behavioral Pediatrics 1996, 17:311-316.
425. Hoffman-Goetz L., Pedersen B.K. Immune responses to acute exercise: hemodynamic, hormonal, and cytokine influences. Psychoneuroimmunology 2001, Vol. 2. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
426. Hogan B.E., Linden W., Najarian B. Social support interventions do they work. Clinical Psychology Review 2002, 381-440.
427. Howell R.T., Kern M.L., Lyubomirsky S. Health benefits: meta-analytically determining the impact of well-being on objective health outcomes. Health Psychology Review 2007, 1:83-136.
428. Hughes D. Nutritional effects on human immune function. Food Allergy and Intolerance 2002, WB Saunders, London. 2nd ed. J. Brostoff, S.J. Challacombe (Eds.).
429. Ironson G., Field T., Scafidi F., et al. Massage therapy is associated with enhancement of the immune system's cytotoxic capacity. International Journal of Neuroscience 1996, 84:205-217.
430. Johnson V.C., Walker L.G., Heys S.D., et al. Can relaxation training and hypnotherapy modify the immune response to stress and is hypnotizability relevant. Contemporary Hypnosis 1996, 13:100-108.
431. Kau A.L., Ahern P.P., Griffin N.W., Goodman A.L., Gordon J.I. Human nutrition, the gut microbiome and the immune system. Nature 2011, 474:327-336.
432. Kiecolt-Glaser J.K. Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosomatic Medicine 2010, 72:365-369.
433. Kiecolt-Glaser J.K., Christian L., Preston H., et al. Stress, inflammation, and yoga practice. Psychosomatic Medicine 2010, 72:113-121.
434. Kiecolt-Glaser J.K., Glaser R., Strain E.C., et al. Modulation of cellular immunity in medical students. Journal of Behavioral Medicine 1986, 9:5-21.
435. Kiecolt-Glaser J.K., Glaser R., Williger D., et al. Psychosocial enhancement of immuno-competence in a geriatric population. Health Psychology 1985, 4:25-41.
436. Kiecolt-Glaser J.K., Gouin J.-P., Hantsoo L. Close relationships, inflammation, and health. Neuroscience and Biobehavioral Reviews 2010, 35:33-38.
437. Kirsch I. The Emperor's New Drugs: Exploding the Antidepressant Myth 2010, Basic Books, New York.
438. Klopfer B. Psychological variables in human cancer. Journal of Projective Techniques 1957, 21:331-340.
439. Krueger J.M., Fang J., Majde J.A. Sleep in health and disease. Psychoneuroimmunology 2001, Vol. 1. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
440. Marsland A.L., Pressman S., Cohen S. Positive affect and immune function. Psychoneuroimmunology 2007, Vol. 2:761-779. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
441. Martin R.A. Humor, laughter, and physical health: methodological issues and research findings. Psychological Bulletin 2001, 127:504-519.
442. Maslowski K.M., Mackay C.R. Diet, gut microbiota and immune responses. Nature Immunology 2011, 12:5-9.
443. McGrady A., Conran P., Dickey D., et al. The effects of biofeedback-assisted relaxation on cell-mediated immunity cortisol, and white blood cell count in healthy adult subjects. Journal of Behavioral Medicine 1992, 15:343-354.
444. Meissner K., Kohls N., Colloca L. Introduction to placebo effects in medicine: mechanisms and clinical implications. Philosophical Transactions of the Royal Society: Biological Sciences 2011, 366:1783-1789.
445. Melmed R.N. Mind, Body, and Medicine: an Integrative Text 2001, Oxford Press, New York.
446. Miller G.E., Cohen S. Psychosocial interventions and the immune system: a meta-analytic review and critique. Health Psychology 2001, 20:47-63.
447. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Reviews Immunology 2008, 8:685-698.
448. Morton D.L., Watson A., El-Deredy W., Jones A.K.P. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain 2009, 146:194-198.
449. Nieman D.C. Exercise and immunity: clinical studies. Psychoneuroimmunology 2007, Vol. 1:661-673. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
450. O'Cleirigh C., Ironson G., Fletcher M.A., Schneiderman N. Written emotional disclosure and processing of trauma are associated with protected health status and immunity in people living with HIV/AIDS. British Journal of Health Psychology 2008, 13:81-84.
451. Opp M.R., Born J., Irwin M.R. Sleep and the immune system. Psychoneuroimmunology 2007, Vol. 1:579-618. Elsevier/Academic Press, San Diego. 4th ed. R. Ader (Ed.).
452. Pace T.W.W., Negi L.T., Adame D.D., et al. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 2009, 34:87-98.
453. Pack A.I., Pien G.W. Update on sleep and its disorders. Annual Review of Medicine 2011, 62:447-460.
454. Peavey B.S., Lawlis G.F., Goven A. Biofeedback assisted relaxation: effects on phagocytic capacity. Biofeedback and Self-Regulation 1985, 10:33-47.
455. Pedersen B.K. Exercise-induced myokines and their role in chronic diseases. Brain, Behavior, and Immunity 2011, 25:811-816.
456. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle derived interleukin-6. Physiological Reviews 2008, 88:1379-1406.
457. Pennebacker J.W. Emotion, Disclosure, and Health 1995, American Psychological Association Press, Washington, DC.
458. Pennebacker J.W., Kiecolt-Glaser J.K., Glaser R. Disclosures of traumas and immune function: health implications for psychotherapy. Journal of Consulting and Clinical Psychology 1988, 56:239-245.
459. Petrie K.J., Fontanilla I., Thomas M.G., Booth R.J., Pennebaker J.W. Effect of written emotional expression on immune function in patients with human immunodeficiency virus infection: a randomized trial. Psychosomatic Medicine 2004, 66:272-275.
460. Pressman S.D., Cohen S. Does positive affect influence health. Psychological Bulletin 2005, 131:925-971.
461. Raz A., Fan J., Posner M.I. Neuroimaging and genetic associations of attentional and hypnotic processes. Journal of Physiology Paris 2006, 99:483-491.
462. Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nature Medicine 2010, 16:1267-1276.
463. Rich G.J. Massage therapy: significance and relevance to professional practice. Professional Psychology: Research and Practice 2010, 41:325-332.
464. Rief W., Mills P.J., Ancoli-Israel S., Ziegler M.G., Pung M.A., Dimsdale J.E. Overnight changes of immune parameters and catecholamines are associated with mood and stress. Psychosomatic Medicine 2010, 72:755-762.
465. Schweinhardt P., Seminowicz D.A., Jaeger E., Duncan G.H., Bushnell C. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. Journal of Neuroscience 2009, 29:4882-4887.
466. Scott D.J., Stohler C.S., Egnatuk C.M., Wang H., Koeppe R.A., Zubieta J.-K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Archives of General Psychiatry 2008, 65:220-231.
467. Selmi C., Tsuneyama K. Nutrition, geoepidemiology, and autoimmunity. Autoimmunity Reviews 2010, 9:A267-A270.
468. Simon H.B. Exercise and human immune function. Psychoneuroimmunology 1991, Academic Press, San Diego. 2nd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
469. Sloan R.P., Bagiella E., Powell T. Religion, spirituality and medicine. Lancet 1999, 353:664-667.
470. Smyth J.M., Pennebacker J.W. Exploring the boundary conditions of expressive writing: in search of the right recipe. British Journal of Health Psychology 2008, 13:1-7.
471. Smyth J.M., Stone A.A., Hurewitz A., Kaell A. Effect of writing about stressful experiences on symptom reduction in patients with asthma and rheumatoid arthritis: a randomized trial. Journal of the American Medical Association 1999, 281:1304-1309.
472. Starkie R., Ostrowski S.R., Jauffred S., Febbraio M., Pedersen B.K. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-α production in humans. FASEB J 2003, 17:884-886.
473. Stefano G.B., Fricchione G.L., Slingsby B.T., Benson H. The placebo effect and relaxation response: neural processes and their coupling to constitutive nitric oxide. Brain Research Reviews 2001, 35:1-19.
474. Sternberg E.M. Healing Spaces: the Science of Place and Well-Being 2009, Harvard University Press, Cambridge.
475. Tracey I. Getting the pain you expect: mechanisms of placebo, nocebo, and reapraisal effects in humans. Nature Medicine 2010, 16:1277-1283.
476. Uchino B.N. Social support and health: a review of physiological processes potentially underlying links to disease outcomes. Journal of Behavioral Medicine 2006, 29:377-387.
477. Udupa K.N., Singh R.H. Yoga in relation to the brain pituitary adrenocortical axis. Interaction within the Brain-Pituitary Adrenocortical System 1979, 273-278. Academic Press, London. M.T. Jones, B. Gillham, M.F. Dallman, S. Chattopadhyay (Eds.).
478. Warnberg J., Cunningham K., Romeo J., Marcos A. Physical activity, exercise and low-grade systemic inflammation. Proceedings of the Nutrition Society 2010, 69:400-406.
479. Way B.M., Taylor S.E. Social influences on health: is serotonin a critical mediator. Psychosomatic Medicine 2010, 72:107-112.
480. Weber C., Arck P., Mazurek B., Klapp B.F. Impact of relaxation training on psychometric and immunologic parameters in tinnitus sufferers. Journal of Psychosomatic Research 2002, 52:29-33.
481. Wegner D.M. The Illusion of Conscious Will 2002, MIT Press, Cambridge.
482. Weinman J., Ebrecht M., Scott S., Walburn J., Dyson M. Enhanced wound healing after emotional disclosure intervention. British Journal of Health Psychology 2008, 13:95-102.
483. Willett W.C. The pursuit of optimal diets: a progress report. Nutritional Genomics: Discovering the Path to Personalized Nutrition 2006, 37-56. John Wiley & Sons, Inc, Hoboken. J. Kaput, R.L. Rodriguez (Eds.).
484. Yoshida S.H., Keen C.L., Ansari A.A., Gershwin M.E. Nutrition and the immune system. Modern Nutrition in Health and Disease 1999, 725-750. Williams & Wilkins, Baltimore. 9th ed. M.E. Shils, J.A. Olson, M. Shike, A.C. Ross (Eds.).
485. Zachariae R. Hypnosis and immunity. Psychoneuroimmunology 2001, Vol. 2. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, R. Cohen (Eds.).
486. Zeitlin D., Keller S.E., Shiflett S.C., et al. Immunological effects of massage therapy during academic stress. Psychosomatic Medicine 2000, 62:83-84.
487. Banks J., Marmot M., Oldfield Z., Smith J.P. Disease and disadvantage in the United States and in England. Journal of the American Medical Association 2006, 295:2037-2045.
488. Barsky A.J. The paradox of health. New England Journal of Medicine 1998, 318:414-418.
489. Bentall R.P. Doctoring the Mind: Is Our Current Treatment of Mental Illness Really Any Good 2009, New York University Press, New York.
490. Bhugra D. Severe mental illness across cultures. Acta Psychiatrica Scandinavica 2006, 113(Suppl. 429):17-23.
491. Bortz W.M. Next Medicine: the Science and Civics of Health 2011, Oxford Press, New York.
492. Callahan D. What Price Better Health Hazards of the Research Imperative 2003, University of California Press, Berkeley.
493. De Vreese L., Weber E., Van Bouwel J. Explanatory pluralism in the medical sciences: theory and practice. Theoretical Medicine and Bioethics 2010, 31:371-390.
494. Fish E.N. The X-files in immunity: sex-based differences predispose immune responses. Nature Reviews Immunology 2008, 8:737-744.
495. Gleick J. Chaos: Making a New Science 1987, Penguin Books, New York.
496. Hadler N.M. The Last Well Person: How to Stay Well Despite the Health-Care System 2004, McGill-Queen's University Press, Montreal.
497. Imarisio S., Carmichael J., Korolchuk V., et al. Huntington's disease: from pathology and genetics to potential therapies. Biochemical Journal 2008, 412:191-209.
498. Health and Healthcare 2010: The Forecast and the Challenge 2000, Institute for the Future, Jossey-Boss, San Francisco.
499. Kauffman S. Investigations 2000, Oxford Press, New York.
500. Kiecolt-Glaser J.K. Psychoneuroimmunology: psychology's gateway to the biomedical future. Perspectives in Psychological Science 2009, 4:367-369.
501. Keicolt-Glaser J.K., McGuire L., Robles T.F., Glaser R. Emotions, morbidity, and mortality: new perspectives from psychoneuroimmunology. Annual Review of Psychology 2002, 53:83-105.
502. Lahey B.B. Public health significance of neuroticism. American Psychologist 2009, 64:241-256.
503. Larton D., Lubahn C., Bellinger D. Introduction to biological signaling in psychoneuroimmunology. Psychoneuroimmunology 2001, Vol. 1. Academic Press, San Diego. 3rd ed. R. Ader, D.L. Felten, N. Cohen (Eds.).
504. Leff J., Sartorius N., Jablensky A., Korten A., Ernberg G. The international pilot study of schizophrenia: five year follow-up findings. Psychological Medicine 1992, 22:131-145.
505. Lutgendorf S.K., Costanzo E.S. Psychoneuroimmunology and health psychology: an integrative model. Brain, Behavior, and Immunity 2003, 17:225-232.
506. Riegelman R. Contributory cause: unnecessary and insufficient. Postgraduate Medicine 1979, 66:177-179.
507. Rosas H.D., Salat D.H., Lee S.Y., et al. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008, 131:1057-1068.
508. Scrivo R., Vasile M., Bartosiewicz I., Valesini G. Inflammation as "common soil" of the multifactorial diseases. Autoimmunity Reviews 2011, 10:369-374.
509. Spiegel D. Mind matters in cancer survival. Journal of the American Medical Association 2011, 305:502-503.
510. Stearns S.C., Nesse R.M., Govindaraju D.R., Ellison P.T. Evolutionary perspectives on health and medicine. Proceedings of the National Academy of Sciences 2010, 107(Suppl. 1):1691-1695.
511. Uher R. The role of genetic variation in the causation of mental illness: an evolution-informed framework. Molecular Psychiatry 2009, 14:1072-1082.